Exosens Shares Bounce Back to €58.20 After a Weekly Decline of 9.56%
Exosens shares recover in the mid-afternoon to €58.20, after a challenging week that saw the stock lose nearly 10%. The specialist in night vision and imaging technologies for defense benefits from a positive session in Paris, with the SBF 120 up by 0.85%. The increase follows the announcement of the consolidation of the group's brands under a single banner.
Technical Rebound from the Lower Bollinger Band After Ten Days of Decline
Exosens shares are trading at the lower end of the Bollinger Band (8%), close to the lower boundary set at €57.21. The price also remains near the support level identified at €56.45, which was tested at the beginning of the week. The RSI at 34 has just exited the oversold zone, indicating seller exhaustion after the weekly decline of 9.56%. Today's rebound is still contained below the 20-day moving average (€63.41), which is 8.22% above the current price. Over a longer horizon, the stock maintains a gain of 72.19% over one year and remains 13.41% above its 200-day moving average (€51.32), signaling that the underlying trend is not compromised by the recent correction.
Tight Valuation Approaching the General Meeting on May 22
Exosens published at the end of April a quarterly revenue increase of 19.7% to €122.6 million, driven by demand in night vision and digital imaging for defense, as detailed in the quarterly publication. The adjusted gross margin improved by 20.1%, despite a decline in the margin rate in Detection & Imaging. Based on the consensus of eight analysts, the stock is trading at about 30.9 times earnings for the current fiscal year and 26.1 times those of the next fiscal year, compared to an 'Industrials' sector average of 18.1 times. The expected growth in earnings per share is 18.4% from one fiscal year to the next. The financial calendar schedules the annual general meeting for May 22, followed by the semi-annual results on July 28, 2026. The support at €56.45 remains the short-term reference level.
